Sentences with phrase «clinical approaches to treatment»
That is why our counselors are trained in a variety of different clinical approaches to treatment that allow them to tailor their approach to the specific, unique needs of our clients.
https://www.polariscounseling.com/
In addition to serving as a Director of the Trauma Studies Center, Rosemary teaches the neurobiology of trauma, clinical approaches to the treatment of trauma and the relevance of attachment theory to trauma.
Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder
Not exact matches
Katherine High, Spark's president and chief scientific officer, expressed her enthusiasm for the early clinical data related to SPK - 8011: «The encouraging start of our SPK - 8011 clinical trial reinforces the strength of our gene therapy platform, delivers human proof - of - concept in a second liver - mediated disease — a significant achievement in the gene therapy field — and positions us well to potentially transform the current treatment approach for this life - altering disease with a one - time intervention.»
Luznik says that the researchers» next step will be to test the short course therapy in a phase III randomized clinical trial that would directly compare results in patients who receive the cyclophosphamide treatment with those who receive either a separate, experimental approach to prevent GVHD or the more traditional six - month immunosuppressive therapy.
As opposed to blunt regulatory solutions that decrease access to opioids in an indiscriminant way, education is a more finely tuned approach that can empower clinicians to make appropriate, well - informed treatment decisions for every patient at each clinical encounter.
And we continue to work with our clinical colleagues to develop new treatment approaches for treating lung disease.»
«Researchers illuminate key role of NOX proteins in liver disease: Study adds credence to new treatment approach now in clinical trials.»
«It's very interesting work but not practical for clinical treatment of patients,» says Denis Paré, a neuroscientist at Rutgers University in New Jersey who is also studying pharmacological approaches to manipulating fearful memories.
«This will be a definitive clinical trial that will help set the course for future DCIS treatment,» said Hwang, who has been a leading voice in the national debate calling for a more informed approach to treating DCIS.
«Techniques to correct defective genes in «non-reproductive» cells are already at various stages of clinical development and promise to be a powerful approach for many human diseases which don't yet have an effective treatment.
Because of the unique multidisciplinary expertise of our team, in less than two years we were able to make an incredible basic science discovery that can be directly translated back to the clinic through an upcoming clinical trial of this new treatment approach for children with DIPG.»
Certain diseases may look the same based on the clinical diagnosis, but we're finding that each patient is a little bit different and may benefit from a personalized approach to treatment.»
Researchers developed a new clinical approach to increase the efficiency of treatment that increased the median survival to 22 months — bringing much needed hope to those affected by this aggressive disease.
Based on recent information on the mechanisms of chemotherapy, a team of researchers of the McGill University Health Centre (MUHC) developed a new clinical approach to increase the efficiency of treatment in glioblastomas that increased the median survival to 22 months — bringing much needed hope to those affected by this aggressive disease.
«At Exeter we are already developing specific psychological therapies, running clinical trials of novel drug approaches and using - cutting edge genetic techniques to identify new targets for safe and effective therapies and to allow us to use current treatments in a more focussed way.»
The approach, says Phan, will benefit patients and providers alike: «We'll be saving a lot of resources on the clinical side, and more importantly, we'll also not be wasting patients» time sending them for a treatment that is not likely to help them.»
«We expect that targeting PLK4 will prove to be an effective and less toxic treatment approach for these children, and we hope to move to a clinical trial soon.»
Innovative clinical trial approaches that have proven successful in other disease areas such as oncology (e.g., platform trials, umbrella and basket designs) might be employed with stratification of subjects by AT (N) profile, enabling a data - driven approach to identify the biological stage of disease in which an intervention has maximal treatment effects.
«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.»
Additional limitations to the traditional approach include: costly failures to replicate positive results in larger trials; difficulty in determining the reasons for negative results; low yield in terms of identifying disease or intervention mechanisms due to an exclusive focus on symptom change and clinical endpoints; and, the expensive and very lengthy practice of first establishing multi-component psychosocial treatments followed by years of «unpacking» studies.
Concepts of how to apply vaccines as part of cancer treatment or as prevention of recurrence, are moving vaccines from being considered a secondary player in cancer clinical management to vaccine approaches gravitating towards becoming a central plank in the newest area of cancer therapy research.
Through the clinical training sessions, Bohus, currently a visiting professor at McLean, provided guidance on his modification of dialectical behavior therapy (DBT) for BPD and complex PTSD to McLean clinicians, marking the first time he has taught his innovative evidence - based treatment approach in the US.
These encouraging data suggest that transient BIO treatment may represent a safe and rapid strategy to enhance the osteogenic potential of patient BM stem cells, a bone defect repair approach that the authors believe is a faster path to clinical translation than the treatment of purified and ex vivo - amplified hMSCs.
The Center for Cancer Immunology Research (CCIR) addresses immunology - based approaches to the treatment of cancer and has emerged as a one - of - a-kind cancer immunology research program that allows laboratory immunologists to work with clinical oncologists to develop new or improved forms of cancer immunotherapy that activate and instruct our immune system to eliminate cancer and prevent its recurrence.
The University of Michigan CF Center takes a multidisciplinary approach to individualize treatment plans and participates in cutting edge clinical trials and research to identify new ways to treat CF.
Douglas J. Schwartzentruber and colleagues at The University of Texas MD Anderson Cancer Center demonstrate that patients with metastatic melanoma receiving high doses of interleukin - 2 (IL - 2) plus a gp100 peptide vaccine had significant improvement in overall clinical response, providing further validation for vaccine approaches to cancer treatment.
Through her Clinical Team Grant, Dr. Bhardwaj and Sacha Gnjatic, Ph.D., are investigating the relationship between checkpoint immunotherapy, chemotherapy, and mutations in advanced bladder cancer, to guide vaccine development and inform combination treatment approaches.
The ultimate goal is to develop new and better approaches for genetic engineering of stem cells to be tested within a clinical trial for the treatment of late stage advanced cancers.
Her clinical focus is aimed at developing a personalized approach to medicine utilizing family history and genetics, creating the best treatment strategy for each patient, rather than relying on the best statistical odds for the majority.
According to Dr. Carter, the findings suggest that future approaches using clinical assessments to identify the specific type of brain dysfunction contributing to a patient's symptoms may allow a more targeted approach to treatment.
The University of Chicago Medicine Inflammatory Bowel Disease Center is made up of a team of experts in clinical care and research, basic science and translational approaches — all working together to further knowledge of IBD causes and treatments.
Maastricht University Medical Center + is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top - level clinical diagnostics and treatment.
This treatment represents a second generation approach to the same telomerase loaded, dendritic cell vaccination immunotherapy strategy that has been tested in two previous clinical trials of our AST - VAC1 product.
Penn's multidisciplinary approach to the diagnosis and treatment of mesothelioma provides better outcomes and gives you access to the most advanced treatment, surgical techniques and clinical trials.
City of Hope patients have access to a wide variety of clinical trials looking into early - detection for lung cancer, the newest chemotherapy treatments, targeted therapies and surgical and radiation approaches — all with the goal of helping extend life.
Clinical responses in lung cancer patients have been impressive, with responses in patients with advance disease whose cancers did not respond to other treatment approaches.
For example, if we had a way to predict a patient's clinical course from their cells» characteristics, we could apply a personalized medicine approach to improve their treatment.
Experts at the Neurosciences Institute participate in clinical trials, giving our patients opportunities to access new treatments and innovations before those approaches are widely available.
The Kessler Foundation Stroke Research Laboratory applies advances in spatial neglect research to clinical care, and will present two abstracts on the exciting prism treatment approach to this disorder.
Liaison between clinical and basic sciences can be utilized to achieve this, including maximizing the potential of genomic data to tailor individualized treatments, collecting natural history information to identify disorder - specific management requirements, developing new therapeutic approaches through improved knowledge of molecular pathways and protein network interactions, and testing potential new drugs via well - conducted clinical trials.
Physicians and scientists work closely together to continually improve the ways in which we diagnose and treat head and neck, brain and spine tumors, and offer our patients access to innovative techniques, new drugs, and clinical trials of the most - advanced treatment approaches.
Learn how severe asthma treatments have gone through clinical trials and have shifted to a more personalized approach.
Dr. Ruscio bases his approach to treatment on the scientific literature that is available and is currently doing clinical research on the treatment of SIBO.
With postgraduate training in clinical Pilates rehabilitation — Mat & Reformer, acupuncture / dry needling, advanced manual therapy, running - specific therapy, and sports therapy, she has developed a well - balanced treatment approach to suit the individual patient's needs.
When it comes down to it, the holistic approach involves taking into account whole - body function and not just focusing on killing cancer cells and can improve a pet's clinical response to treatment.
Integrative medicine includes a comprehensive approach to veterinary medicine that complements conventional diagnostic and treatment modalities to optimize clinical outcome.
In Part 1 of her four - part series on veterinary dermatology in shelter and foster home pets, Clinical Associate Professor of Dermatology, Dr. Karen Moriello, will tackle this tough problem with a special focus on approaches suitable to the limited resources of shelters and rescue groups, and the role of foster families in the treatment of itchy dogs.
It is hard to decide when the clinical signs justify treatment without supporting lab values but if your vet really feels strongly that Cushing's disease is present and suggests treatment for it, I think that there are times when it is reasonable to try that approach.
Treating a dog with diarrhea requires that a veterinarian take a complete history and review the clinical record in order to define the degree of severity and approach towards treatment that is needed.